Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases
Dan Pu, Zhe Zhang, Bai‐Sui Feng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18

Showing 18 citing articles:

Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 45
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier
D. Rondinella, Pauline Raoul, Eleonora Valeriani, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 859-859
Open Access | Times Cited: 2
Armored probiotics for oral delivery
Xinyuan Yang, Chong Wang, Qiao Wang, et al.
Smart Medicine (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 21
Endocrine-Disrupting Chemicals, Gut Microbiota, and Human (In)Fertility—It Is Time to Consider the Triad
Gemma Fabozzi, Paola Rebuzzini, Danilo Cimadomo, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3335-3335
Open Access | Times Cited: 23
Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
Domingo Balderramo
World Journal of Gastroenterology (2022) Vol. 28, Iss. 47, pp. 6743-6751
Open Access | Times Cited: 19
Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis
Keyu Ren, Chunming Yong, Yanchun Jin, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Culture-based characterization of gut microbiota in inflammatory bowel disease
Hyunjoon Park, Soyoung Yeo, Taekyu Lee, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Potential Benefits of Egg White Proteins and Their Derived Peptides in the Regulation of the Intestinal Barrier and Gut Microbiota: A Comprehensive Review
Qi Yang, Siwen Lyu, Meng−Lei Xu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 36, pp. 13168-13180
Closed Access | Times Cited: 10
Bioactive Components in Fruit Interact with Gut Microbes
Yuanyuan Jin, Ling Chen, Yufen Yu, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1333-1333
Open Access | Times Cited: 9
Microbiota and Gut Health: Promising Prospects for Clinical Trials from Bench to Bedside
Jie Wang, Puxuan Zhang, Shujie Chen, et al.
Advanced Gut & Microbiome Research (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 15
Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis
Sweta Ghosh, Bhagavatula Moorthy, Bodduluri Haribabu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Effectiveness of probiotic- and fish oil-loaded water-in-oil-in-water (W1/O/W2) emulsions at alleviating ulcerative colitis
Qingzhuo Gu, Zhaowei Jiang, Kun Li, et al.
Food & Function (2024) Vol. 15, Iss. 11, pp. 5797-5812
Closed Access | Times Cited: 2
Self-Perceived Physical Level and Fitness Performance in Children and Adolescents with Inflammatory Bowel Disease
Francesca Penagini, Valeria Calcaterra, Dario Dilillo, et al.
Children (2022) Vol. 9, Iss. 9, pp. 1399-1399
Open Access | Times Cited: 3
Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?
Dan Pu, Pengfei Wang, Xiang Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112943-112943
Closed Access
Focusing on Non-Responders to Infliximab with Ulcerative Colitis, What Can We Do First and Next?
Dan Pu, Pengfei Wang, Xiang Wang, et al.
(2024)
Closed Access
Revisão das opções de tratamento convencionais e emergentes para doenças inflamatórias intestinais: uma revisão bibliográfica
Francisco Plawthyney da Silva Nogueira, Carlos Alberto Teles de Sousa Neto, GISELE CARNEIRO DA CUNHA, et al.
Cuadernos de Educación y Desarrollo (2024) Vol. 16, Iss. 7, pp. e4732-e4732
Closed Access
Long-term Pu-erh tea alleviates inflammatory bowel disease via the regulation of intestinal microbiota and maintaining the intestinal mucosal barrier
Bi-Yun Feng, Pei-Lu Chen, Ling Yan, et al.
Food Science and Biotechnology (2024) Vol. 34, Iss. 3, pp. 743-755
Closed Access
Gut microbiota in inflammatory bowel disease: a combined culturomics and metagenomics perspective
Hyunjoon Park, Soyoung Yeo, Taekyu Lee, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top